Pasithea Therapeutics (KTTA) Intangibles (2022 - 2024)
Pasithea Therapeutics (KTTA) has disclosed Intangibles for 3 consecutive years, with $7.5 million as the latest value for Q3 2024.
- Quarterly Intangibles fell 7.78% to $7.5 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $7.5 million through Sep 2024, down 7.78% year-over-year, with the annual reading at $7.9 million for FY2023, 7.35% down from the prior year.
- Intangibles hit $7.5 million in Q3 2024 for Pasithea Therapeutics, down from $8.6 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $8.6 million in Q4 2022 to a low of $12502.0 in Q3 2022.
- Historically, Intangibles has averaged $7.3 million across 3 years, with a median of $8.3 million in 2023.
- Biggest five-year swings in Intangibles: skyrocketed 64680.48% in 2023 and later decreased 7.78% in 2024.
- Year by year, Intangibles stood at $8.6 million in 2022, then decreased by 7.35% to $7.9 million in 2023, then decreased by 5.95% to $7.5 million in 2024.
- Business Quant data shows Intangibles for KTTA at $7.5 million in Q3 2024, $8.6 million in Q2 2024, and $8.6 million in Q1 2024.